IVD Industry Update: Is UK Still Missing The Point In The Innovation vs Adoption Debate?
This article was originally published in Clinica
Executive Summary
There is much to commend in the UK Office for Life Sciences’ Accelerated Access Review (AAR) project. Launched earlier this year by minister for life sciences George Freeman and initially known as the Innovative Medicines and Medical Technology Review (IMMTR), its broad aim is to remove the barriers to the use of transformative health technologies.